PMID: 9547357May 9, 1998Paper

(-)-CGP 12177 causes cardiostimulation and binds to cardiac putative beta 4-adrenoceptors in both wild-type and beta 3-adrenoceptor knockout mice

Molecular Pharmacology
A J KaumannJ P Giacobino

Abstract

Some blockers of beta1- and beta2-adrenoceptors cause cardiostimulant effects through an atypical beta-adrenoceptor (putative beta4-adrenoceptor) that resembles the beta3-adrenoceptor. It is likely but not proven that the putative beta4-adrenoceptor is genetically distinct from the beta3-adrenoceptor. We therefore investigated whether or not the cardiac atypical beta-adrenoceptor could mediate agonist effects in mice lacking a functional beta3-adrenoceptor gene (beta3 KO). (-)-CGP 12177, a beta1- and beta2-adrenoceptor blocker that causes agonist effects through both beta3-adrenoceptors and cardiac putative beta4-adrenoceptors, caused cardiostimulant effects that were not different in atria from wild-type (WT) mice and beta3 KO mice. The effects of (-)-CGP 12177 were resistant to blockade by (-)-propranolol (200 nM) but were blocked by (-)-bupranolol (1 microM) with an equilibrium dissociation constant of 15 nM in WT and 17 nM in beta3 KO. (-)-[3H]CGP 12177 labeled a similar density of the putative beta4-adrenoceptor in ventricular membranes from the hearts of both WT (Bmax = 52 fmol/mg protein) and beta3 KO (Bmax = 53 fmol/mg protein) mice. The affinity of (-)-[3H]CGP 12177 for the cardiac putative beta4-adrenoceptor was not d...Continue Reading

References

Jul 9, 1991·European Journal of Pharmacology·D LanginM Lafontan
Nov 1, 1990·Naunyn-Schmiedeberg's Archives of Pharmacology·A J Kaumann
Aug 1, 1989·Trends in Pharmacological Sciences·A J Kaumann
Jul 1, 1965·Journal of Applied Physiology·J R Blinks
Dec 8, 1995·The Journal of Biological Chemistry·V S SusulicB B Lowell
Apr 28, 1995·European Journal of Pharmacology·D E BerkowitzD A Schwinn
Jul 1, 1995·Trends in Pharmacological Sciences·T Kenakin
Apr 1, 1995·European Journal of Endocrinology·J P Giacobino
Nov 1, 1993·British Journal of Pharmacology·F LönnqvistP Arner
Jul 1, 1994·British Journal of Pharmacology·N BlinA D Strosberg
Nov 1, 1993·Medicinal Research Reviews·J R Arch, A J Kaumann
Jan 1, 1993·The Journal of Clinical Investigation·S KriefL J Emorine
Jun 14, 1993·FEBS Letters·J M LeliasP Ferrara
Jul 15, 1996·The Journal of Clinical Investigation·C GauthierH Le Marec
Aug 1, 1996·British Journal of Pharmacology·A J Kaumann, P Molenaar
Oct 1, 1996·Trends in Pharmacological Sciences·A D Strosberg, F Pietri-Rouxel
Mar 1, 1997·Trends in Pharmacological Sciences·A J Kaumann
Jun 1, 1997·Naunyn-Schmiedeberg's Archives of Pharmacology·A J Kaumann, P Molenaar
Mar 21, 1998·British Journal of Pharmacology·D SarseroA J Kaumann

❮ Previous
Next ❯

Citations

Mar 11, 2000·American Journal of Respiratory and Critical Care Medicine·G P Anderson
Feb 13, 2001·British Journal of Pharmacology·D S HutchinsonR J Summers
Oct 18, 2001·Science's STKE : Signal Transduction Knowledge Environment·R P Xiao
Jan 2, 2003·Nature Reviews. Drug Discovery·Brian P Zambrowicz, Arthur T Sands
Mar 17, 2007·Heart Failure Reviews·V Melih AltanA Tanju Ozcelikay
Feb 26, 2019·British Journal of Pharmacology·Ebru Arioglu-InanMartin C Michel
Feb 28, 2002·The Journal of Pharmacology and Experimental Therapeutics·Andreas BundkirchenRobert H G Schwinger
Jan 11, 2007·Naunyn-Schmiedeberg's Archives of Pharmacology·Wim Vrydag, Martin C Michel
Sep 10, 2005·British Journal of Pharmacology·Agnieszka ZakrzeskaBarbara Malinowska
Apr 1, 2011·Therapeutic Advances in Endocrinology and Metabolism·Jonathan R S Arch
Oct 30, 2004·British Journal of Pharmacology·Jonathan R S Arch
Jun 9, 2005·Molecular Pharmacology·Geneviève TavernierDominique Langin
Aug 16, 2008·The Journal of Clinical Investigation·V Arvydas SkeberdisRodolphe Fischmeister
Apr 1, 2000·British Journal of Pharmacology·P ViardJ Mironneau
Sep 19, 2002·British Journal of Pharmacology·Jillian G BakerStephen J Hill
Apr 30, 2003·Journal of Cardiovascular Pharmacology·Valery I KozlovskiRichard J Gryglewski
Dec 25, 2007·British Journal of Pharmacology·J G Baker
Feb 13, 2001·American Journal of Physiology. Endocrinology and Metabolism·J G Granneman
May 20, 1999·Annual Review of Pharmacology and Toxicology·S R PostP A Insel
Feb 18, 2005·The Journal of Pharmacology and Experimental Therapeutics·Jillian G Baker
Sep 12, 2003·British Journal of Pharmacology·Peter Molenaar
Aug 10, 2000·Pulmonary Pharmacology & Therapeutics·E NalineC Advenier
Dec 21, 2000·Trends in Pharmacological Sciences·C GauthierJ L Balligand
May 7, 2003·Biochemical Pharmacology·Rangaswamy NagmaniDennis R Feller
Aug 26, 2006·Bioorganic & Medicinal Chemistry Letters·Don R FinleyCynthia D Jesudason

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.